India’s Panacea Biotec To Make 100 Million Sputnik Vaccine Doses Annually: Document
The Russian Direct Funding Fund didn’t say when manufacturing would start.
Moscow:
Indian biotech company Panacea Biotec Ltd has agreed to supply 100 million doses of Russia’s Sputnik V COVID-19 vaccine yearly, the Russian Direct Funding Fund (RDIF), which markets the shot across the world, stated on Monday.
RDIF didn’t say when manufacturing would start.
(Apart from for the headline, this tale has no longer been edited via TTN NEWS workforce and is revealed from a syndicated feed.)
